|Mr. David A. Rosa M.D.||CEO, Pres & Director||587.01k||N/A||1964|
|Mr. Steven Mertens||Chief Technology Officer||290.97k||N/A||1963|
|Mr. Ronald W. McClurg||Chief Financial Officer||N/A||N/A||1959|
|Ms. Leah Noaeill||Sr. Director of Marketing||N/A||N/A||N/A|
NeuroOne Medical Technologies Corporation operates as a medical technology company. It focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and other related brain related disorders. NeuroOne Medical Technologies Corporation has a strategic partnership with RBC Medical Innovations to develop and manufacture a radiofrequency generator for use with NeuroOne's combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode. The company is based in Eden Prairie, Minnesota.
NeuroOne Medical Technologies Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.